BIOCRYST PHARMACEUTICALS INC reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Durham, NC
SEC filing record 1 source field available
Fiscal year end
31 December
BIOCRYST PHARMACEUTICALS INC has filed 1,953 SEC EDGAR filings since 14 Feb 1995

SEC filing history

Showing 776-800 of 1,000 matching filings.

Per page
25
Current page
32
425 File 000-23186

425

Filing date
02 Apr 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 000-23186

425

Filing date
02 Apr 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFM14A File 000-23186

DEFM14A

Filing date
29 Mar 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K/A File 000-23186

FORM 10-K/A

Filing date
27 Mar 2018
Reporting date
31 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 000-23186

425

Filing date
22 Mar 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 000-23186

425

Filing date
22 Mar 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-23186

FORM 8-K

Filing date
15 Mar 2018
Reporting date
15 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 000-23186

425

Filing date
08 Mar 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
08 Mar 2018
Reporting date
06 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 000-23186

425

Filing date
07 Mar 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
02 Mar 2018
Reporting date
28 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
02 Mar 2018
Reporting date
28 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
02 Mar 2018
Reporting date
01 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
02 Mar 2018
Reporting date
01 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 000-23186

425 filing

Filing date
28 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-23186

FORM 8-K

Filing date
28 Feb 2018
Reporting date
28 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 000-23186

425

Filing date
27 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 000-23186

425

Filing date
27 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-23186

8-K

Filing date
27 Feb 2018
Reporting date
27 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 000-23186

425

Filing date
27 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 000-23186

425

Filing date
27 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 000-23186

425

Filing date
27 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 000-23186

425

Filing date
27 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 000-23186

425

Filing date
23 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .